MedPath

RITUXAN SC

RITUXAN SC

Approved
DIN Number

02457350

Drug Class

Human

Market Date

Nov 22, 2016

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02457350
AIG Number0140241002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L01FA01 RITUXIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

RITUXIMABActive
Strength: 1400 MG / 11.7 ML
Monograph: RITUXIMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.